MedWatch

No needles in sight as Novo succeeds with new capsule technology

Novo Nordisk has reached an important milestone in its partnership with US university MIT. Its new technology opens the doors to big opportunities, but the road ahead is long, says the VP of Novo Nordisk.

Photo: PR/Novo Nordisk

The pharmaceutical company Novo Nordisk has achieved somewhat of a milestone in its collaboration with the world-famous university, Massachusetts Institute of Technology (MIT).

A completely new type of technology has shown itself capable of breaking an essential barrier in pigs.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs